Cheryl L. Willman, M.D.

Director & CEO, UNM Comprehensive Cancer Center
Distinguished Professor, Department of Pathology
The Maurice and Marguerite Liberman Distinguished Chair in Cancer Research
The University of New Mexico
2015 STC Innovation Fellow

Over the past 20 years, Dr. Willman has served as the Director and CEO of the UNM Comprehensive Cancer Center (UNMCCC). She pioneered the development of the clinical, research, education, and community outreach programs of the UNMCCC, culminating in 2015 in its designation as one of the nation’s 50 NCI Designated Comprehensive Cancer Centers. In addition to her role in the UNM CCC, Dr. Willman is an internationally recognized physician-scientist and a national leader in cancer precision medicine and leukemia research. Her research focuses on the use of genomic and computational technologies to identify novel cancer-causing DNA mutations that can be translated to better cancer diagnostics and therapeutics.